Idorsia (LTS:0RQE) Other Long-Term Liabilities : CHF173.7 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Other Long-Term Liabilities?

Idorsia's other long-term liabilities for the quarter that ended in Sep. 2023 was CHF173.7 Mil.

Idorsia's quarterly other long-term liabilities declined from Mar. 2023 (CHF176.6 Mil) to Jun. 2023 (CHF174.2 Mil) and declined from Jun. 2023 (CHF174.2 Mil) to Sep. 2023 (CHF173.7 Mil).

Idorsia's annual other long-term liabilities declined from Dec. 2020 (CHF25.5 Mil) to Dec. 2021 (CHF11.9 Mil) but then increased from Dec. 2021 (CHF11.9 Mil) to Dec. 2022 (CHF176.3 Mil).

Idorsia Other Long-Term Liabilities Historical Data

The historical data trend for Idorsia's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Other Long-Term Liabilities Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long-Term Liabilities

Get a 7-Day Free Trial

Idorsia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Idorsia Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Idorsia Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Idorsia's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia (LTS:0RQE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (LTS:0RQE) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

IDRSF:USA IDIAz:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia (LTS:0RQE) Headlines

No Headlines